Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


06.05.2024

1 Ann Surg Oncol
1 BMC Ophthalmol
1 Cancer
1 Clin Exp Metastasis
2 J Am Acad Dermatol
1 J Clin Invest


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. LIANG C, Li D, Liang Y, Xie Y, et al
    Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study.
    Ann Surg Oncol. 2024 Apr 30. doi: 10.1245/s10434-024-15327.
    PubMed         Abstract available


    BMC Ophthalmol

  2. ZHAN Z, Lin K, Wang T
    Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    BMC Ophthalmol. 2024;24:204.
    PubMed         Abstract available


    Cancer

  3. KHATTAK MA, Luke JJ
    Top advances of the year: Melanoma.
    Cancer. 2024 Apr 29. doi: 10.1002/cncr.35354.
    PubMed        


    Clin Exp Metastasis

  4. KHAN I, Kashani-Sabet M
    Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
    Clin Exp Metastasis. 2024 Apr 29. doi: 10.1007/s10585-024-10265.
    PubMed         Abstract available


    J Am Acad Dermatol

  5. KOGA S, Du W, Ono D
    Response to "Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.".
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00671.
    PubMed        

  6. DESAI AD, Ibrahim SJ, Samie FH
    Evaluating the benefit of immunotherapy for Stage III melanoma.
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00679.
    PubMed        


    J Clin Invest

  7. HUANG F, Goncalves C, Bartish M, Remy-Sarrazin J, et al
    Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
    J Clin Invest. 2024;134:e181575.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.